Načítá se...
Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives
Thyroid cancer is the most common endocrine malignancy, with over 60,000 cases reported per year in the US alone. The incidence of thyroid cancer has increased in the last several years. Patients with metastatic differentiated thyroid cancer (DTC) generally have a good prognosis. Metastatic DTC can...
Uloženo v:
Vydáno v: | Drug Des Devel Ther |
---|---|
Hlavní autoři: | , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Dove Medical Press
2016
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4778792/ https://ncbi.nlm.nih.gov/pubmed/27013865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S93459 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|